Multiple sclerosis (ms)
Multiple Sclerosis (MS) is a chronic neurological condition that affects the central nervous system, which includes the brain, spinal cord, and optic nerves. It is an autoimmune disease, meaning the immune system mistakenly attacks the body’s own healthy cells. In the case of MS, it attacks the protective coating, called myelin, surrounding the nerve fibers, causing communication problems between the brain and the rest of the body.
MS can manifest with a variety of symptoms, such as muscle weakness, balance and coordination problems, numbness or tingling in the limbs, difficulty with vision, and fatigue. The severity and progression of the disease vary greatly among individuals, with some experiencing only mild symptoms while others may face significant disability.
There is currently no cure for MS, but several medications are available to manage the disease and alleviate symptoms. These treatments can be broadly categorized into three main types:
Disease-modifying therapies (DMTs): These medications aim to reduce the frequency and severity of relapses, slow down the progression of the disease, and prevent new areas of damage in the central nervous system. Examples of DMTs include interferon beta, glatiramer acetate, teriflunomide, dimethyl fumarate, and monoclonal antibodies like ocrelizumab, alemtuzumab, and natalizumab.
Symptomatic therapies: These medications target specific symptoms experienced by individuals with MS, such as muscle spasticity, pain, fatigue, and bladder or bowel dysfunction. Examples include baclofen, tizanidine, gabapentin, pregabalin, and duloxetine.
Disease management and support: Medications that help manage the overall health of individuals with MS, such as treating infections and managing co-existing conditions like depression and anxiety. Examples include antibiotics, antidepressants, and anti-anxiety medications.
Consult with a healthcare professional to determine the most appropriate treatment plan for each individual with MS, considering factors such as the severity of the disease, the presence of other health conditions, and potential side effects of medications. Regular monitoring and follow-up with healthcare professionals are essential for effective disease management and optimal quality of life.

Showing 1–12 of 24 results
-
Dalfampridine (1)
-
Dimethyl fumarate (15)
-
Fingolimod (1)
-
Glatiramer Acetate (2)
-
Interferon Beta-1A (4)
-
Natalizumab (1)
Showing 1–12 of 24 results